One important biomarker of PC is prostate-specific membrane antigen (PSMA), which is overexpressed in most PCs (5,6); its higher expression is associated with castration-resistant disease (7,8) and inferior metastasis-free survival (9–11). This evidence concerns the gene FOLH1 and pachyonychia congenita.